Article
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
The new microbiologica - 1 May 2024
Panza Francesca, Saladini Francesco, Bartolini Niccolò, Gianmarino Federica, Montagnani Francesca, Spagnuolo Vincenzo, Tumbarello Mario, Santoro Maria Mercedes, Castagna Antonella, Zazzi Maurizio, Fabbiani Massimiliano
Abstract excerpt
Management of virological failure in heavily treatment-experienced people with multidrug-resistant (MDR) HIV infection is a serious clinical challenge. New drugs with novel mechanisms of action have recently been approved, and their use has improved the outcome of subjects with limited treatment options (LTO). In this setting, the choice of antiretroviral therapy (ART) should be tailored based on the pattern of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.